{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:45:14Z","timestamp":1785451514002,"version":"3.56.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13256-018-1708-x","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T15:28:09Z","timestamp":1529076489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Combination therapy of ipilimumab and nivolumab induced thyroid storm in a patient with Hashimoto\u2019s disease and diabetes mellitus: a case report"],"prefix":"10.1186","volume":"12","author":[{"given":"Kazuko","family":"Yonezaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Imachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuo","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensaku","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seisuke","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Ibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Yamaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Murao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"issue":"12","key":"1708_CR1","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1507\/endocrj.EJ16-0336","volume":"63","author":"T Satoh","year":"2016","unstructured":"Satoh T, Isozaki O, Suzuki A, Wakino S, Iburi T, Tsuboi K, et al. 2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition). Endocr J. 2016;63(12):1025\u201364. PubMed PMID: 27746415.","journal-title":"Endocr J"},{"issue":"4","key":"1708_CR2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252\u201364. PubMed PMID: 22437870.","journal-title":"Nat Rev Cancer"},{"key":"1708_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-med-092012-112807","volume":"65","author":"DB Page","year":"2014","unstructured":"Page DB, Postow MA, Callahan MK, Allison JP, Wolchok JD. Immune modulation in cancer with antibodies. Annu Rev Med. 2014;65:185\u2013202. PubMed PMID: 24188664.","journal-title":"Annu Rev Med"},{"issue":"9","key":"1708_CR4","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1093\/annonc\/mdv182","volume":"26","author":"TW Chen","year":"2015","unstructured":"Chen TW, Razak AR, Bedard PL, Siu LL, Hansen AR. A systematic review of immune-related adverse event reporting in clinical trials of immune checkpoint inhibitors. Ann Oncol. 2015;26(9):1824\u20139. PubMed PMID: 25888611.","journal-title":"Ann Oncol"},{"issue":"28","key":"1708_CR5","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1200\/JCO.2015.60.8448","volume":"33","author":"TZ Horvat","year":"2015","unstructured":"Horvat TZ, Adel NG, Dang TO, Momtaz P, Postow MA, Callahan MK, et al. Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center. J Clin Oncol. 2015;33(28):3193\u20138. PubMed PMID: 26282644.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1708_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0889-8529(18)30165-8","volume":"22","author":"HB Burch","year":"1993","unstructured":"Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin N Am. 1993;22(2):263\u201377. PubMed PMID: 8325286.","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"1","key":"1708_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/oxfordjournals.eurheartj.a060032","volume":"13","author":"JL Georges","year":"1992","unstructured":"Georges JL, Normand JP, Lenormand ME, Schwob J. Life-threatening thyrotoxicosis induced by amiodarone in patients with benign heart disease. Eur Heart J. 1992;13(1):129\u201332. PubMed PMID: 1577019.","journal-title":"Eur Heart J"},{"issue":"16","key":"1708_CR8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1200\/JCO.2012.46.7142","volume":"31","author":"S Haraldsdottir","year":"2013","unstructured":"Haraldsdottir S, Li Q, Villalona-Calero MA, Olencki TE, Kendra K, Ing SW. Case of sorafenib-induced thyroid storm. J Clin Oncol. 2013;31(16):262\u20134. PubMed PMID: 23610115.","journal-title":"J Clin Oncol"},{"key":"1708_CR9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/bcr-2016-214603","volume":"2016","author":"B McMillen","year":"2016","unstructured":"McMillen B, Dhillon MS, Yong-Yow S. A rare case of thyroid storm. BMJ Case Rep. 2016;2016:10. PubMed PMID: 27090545.","journal-title":"BMJ Case Rep"},{"key":"1708_CR10","first-page":"140092","volume":"2015","author":"C Yu","year":"2015","unstructured":"Yu C, Chopra IJ, Ha E. A novel melanoma therapy stirs up a storm: ipilimumab-induced thyrotoxicosis. Endocrinol Diabetes Metab Case Rep. 2015;2015:140092. PubMed PMID: 25759760.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"1","key":"1708_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","volume":"373","author":"J Larkin","year":"2015","unstructured":"Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Cowey CL, Lao CD, et al. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. N Engl J Med. 2015;373(1):23\u201334. PubMed PMID: 26027431.","journal-title":"N Engl J Med"},{"issue":"21","key":"1708_CR12","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","volume":"372","author":"MA Postow","year":"2015","unstructured":"Postow MA, Chesney J, Pavlick AC, Robert C, Grossmann K, McDermott D, et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N Engl J Med. 2015;372(21):2006\u201317. PubMed PMID: 25891304.","journal-title":"N Engl J Med"},{"issue":"4","key":"1708_CR13","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/cen.13297","volume":"86","author":"DL Morganstein","year":"2017","unstructured":"Morganstein DL, Lai Z, Spain L, Diem S, Levine D, Mace C, et al. Thyroid abnormalities following the use of cytotoxic T-lymphocyte antigen-4 and programmed death receptor protein-1 inhibitors in the treatment of melanoma. Clin Endocrinol. 2017;86(4):614\u201320. PubMed PMID: 28028828.","journal-title":"Clin Endocrinol"},{"key":"1708_CR14","first-page":"2087525","volume":"2016","author":"U Azmat","year":"2016","unstructured":"Azmat U, Liebner D, Joehlin-Price A, Agrawal A, Nabhan F. Treatment of Ipilimumab Induced Graves\u2019 Disease in a Patient with Metastatic Melanoma. Case Rep Endocrinol. 2016;2016:2087525. PubMed PMID: 26881150.","journal-title":"Case Rep Endocrinol"},{"issue":"3","key":"1708_CR15","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1210\/endo-120-3-1033","volume":"120","author":"AC Bianco","year":"1987","unstructured":"Bianco AC, Nunes MT, Hell NS, Maciel RM. The role of glucocorticoids in the stress-induced reduction of extrathyroidal 3,5,3\u2032-triiodothyronine generation in rats. Endocrinology. 1987;120(3):1033\u20138. PubMed PMID: 3803308.","journal-title":"Endocrinology"},{"issue":"11","key":"1708_CR16","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.2337\/dc15-1331","volume":"38","author":"C Gaudy","year":"2015","unstructured":"Gaudy C, Cl\u00e9vy C, Monestier S, Dubois N, Pr\u00e9au Y, Mallet S, et al. Anti-PD1 Pembrolizumab Can Induce Exceptional Fulminant Type 1 Diabetes. Diabetes Care. 2015;38(11):e182\u20133. PubMed PMID: 26310693.","journal-title":"Diabetes Care"},{"issue":"4","key":"1708_CR17","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2337\/dc14-2349","volume":"38","author":"J Hughes","year":"2015","unstructured":"Hughes J, Vudattu N, Sznol M, Gettinger S, Kluger H, Lupsa B, et al. Precipitation of autoimmune diabetes with anti-PD-1 immunotherapy. Diabetes Care. 2015;38(4):e55\u20137. PubMed PMID: 25805871.","journal-title":"Diabetes Care"},{"issue":"3","key":"1708_CR18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/pedi.12148","volume":"15","author":"M Jaberi-Douraki","year":"2014","unstructured":"Jaberi-Douraki M, Liu SW, Pietropaolo M, Khadra A. Autoimmune responses in T1DM: quantitative methods to understand onset, progression, and prevention of disease. Pediatr Diabetes. 2014;15(3):162\u201374. PubMed PMID: 24827702.","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"1708_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1084\/jem.20022125","volume":"198","author":"MJ Ansari","year":"2003","unstructured":"Ansari MJ, Salama AD, Chitnis T, Smith RN, Yagita H, Akiba H, et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med. 2003;198(1):63\u20139. PubMed PMID: 12847137.","journal-title":"J Exp Med"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1708-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-018-1708-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1708-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T04:26:05Z","timestamp":1751689565000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-018-1708-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1708"],"URL":"https:\/\/doi.org\/10.1186\/s13256-018-1708-x","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]},"assertion":[{"value":"6 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is approved by the ethics committee of Faculty of Medicine, Kagawa University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"171"}}